Extremities Hospitals Anika Announces Regulatory Approval for MONOVISC® in Australia byJosh SandbergOctober 16, 2017
Financial Top Stories Anika Announces $5 Million Milestone Payment from U.S. Commercial Sales of MONOVISC byJosh SandbergJuly 18, 2017
Extremities Hospitals Anika Therapeutics Files Investigational Device Exemption to Initiate Phase III Study to Expand Indication of MONOVISC® to Treat Pain Caused by Osteoarthritis of the Hip byJosh SandbergJune 23, 2015
